Selling And Administration Expenses 変化する 日付
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Biogen USD 608.5M 179.7M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Cytokinetics USD 44.11M 4M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
J&J USD 5.81B 410M 2023-12
Marinus Pharmaceuticals USD 14.87M 854K 2023-09
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
RedHill Biopharma USD 8.06M 2.85M 2023-06
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
United Therapeutics USD 128.6M 1000K 2023-12
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06



Intra Cellular Therapies 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2024.